Societe Generale’s GSK GSK Stock Holding History

Societe Generale’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$291K	Buy	+5,380	New	+$283K	﹤0.01%	1950

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Societe Generale's GSK Position: Q2 2016 in Review

Societe Generale opened a new position in GSK (GSK) in Q2 2016: 5,380 shares worth $291K. The stake represents ﹤0.01% of the portfolio and ranks #1950 among its holdings.

741 funds tracked by Wall St. Rank hold GSK as of Q2 2016.

Societe Generale held 5,380 shares of GSK worth $291K as of Q2 2016.
GSK was a new Societe Generale position in Q2 2016.
GSK made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #1950 holding.
741 funds tracked by Wall St. Rank held GSK as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.